Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-20

FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Varithena (polidocanol) by Biocompatibles, Inc., expanding the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varithena (polidocanol injectable foam)

Snippet

SUPPL AP for VARITHENA (POLIDOCANOL)